Advanced Podiatric Sprays Presentation

Advanced Podiatric Solutions

DermaSept+ HOCl & MicroCure+ Ag+

Targeted Antimicrobial Sprays for Foot & Wound Care

For Podiatrists & Wound Care Specialists | Malaysia

The Critical Challenge in Podiatry: The Diabetic Foot

Diabetic Foot Ulcer Graphic

Malaysia has one of the highest rates of diabetes in Asia. Consequently, Diabetic Foot Ulcers (DFUs) are a leading cause of hospitalization and are directly linked to a staggering 7,000 lower limb amputations annually1.

Effective bioburden control is paramount to preventing infection and promoting healing.

Limitations of Traditional Antiseptics

Standard agents can present challenges in modern wound care.

Povidone-Iodine

Limitation:

Demonstrated cytotoxicity to fibroblasts and keratinocytes, potentially delaying wound healing. Can also stain tissue.

Topical Antibiotics

Limitation:

Growing concerns over bacterial resistance and potential for contact dermatitis.

Two Advanced Tools, Specific Clinical Roles

Selecting the right technology for the right phase of care.

HOCl Spray

DermaSept+ HOCl

For Cleansing & Debridement

  • Initial cleansing of a new or contaminated wound.
  • Flushing ulcers during dressing changes to remove slough.
  • Reducing inflammation and odor in infected wounds.
  • Breaking down stubborn biofilm.
Silver Spray

MicroCure+ Ag+

For Sustained Protection

  • Daily prevention on at-risk, intact skin (e.g., neuropathic foot).
  • Applying a sustained antimicrobial barrier under dressings.
  • Managing bioburden in chronic, slow-healing wounds.
  • Preventing fungal infections like tinea pedis.

Visualizing the Antimicrobial Action

Rapid Oxidative Action

Stabilized Hypochlorous Acid (HOCl) physically destroys the cell walls of bacteria, fungi, and viruses on contact. It also denatures key proteins within biofilm, helping to break down this protective barrier and expose the underlying microbes.

Evidence-Based Wound Management

Both technologies are supported by extensive clinical research.

HOCl Efficacy2

>5-log Reduction

In bioburden of both planktonic and biofilm-forming bacteria (P. aeruginosa, S. aureus) within minutes.

Nano Silver Efficacy3

7-Day Activity

Sustained antimicrobial activity against common wound pathogens, making it ideal for use under dressings.

Supporting Clinical Data: Visualizing the Impact

Quantitative results from in-vitro studies demonstrating superior performance.

DermaSept+ HOCl: Rapid Biofilm Eradication

Control (Untreated Biofilm)
100% Viability
After HOCl (5 min)
<1%

Within minutes, HOCl achieves a >99.99% reduction in viable biofilm, clearing the way for healing to begin.2

MicroCure+ Ag+: Sustained Antimicrobial Barrier

Control (Bacterial Growth)
Uninhibited
Nano Ag+ (Activity at Day 7)
Inhibited

Nano Silver provides a durable zone of inhibition, preventing microbial recolonization for up to 7 days.3

Integrated Care Protocol

62-Year-Old Patient with a Wagner Grade 2 Diabetic Foot Ulcer

Treatment Protocol:

  • Week 1-2 (Cleansing Phase): After debridement, cleanse wound with DermaSept+ HOCl at each dressing change to reduce bioburden and slough.
  • Week 3+ (Protective Phase): Once granulation tissue is present, switch to MicroCure+ Ag+ applied to the wound bed before dressing to provide sustained antimicrobial protection.

Outcome: Significant reduction in wound size and signs of infection by week 4, with healthy granulation tissue filling the wound bed.

Preserving Limbs, Improving Lives

A proactive and reactive strategy for comprehensive foot care.

Reduce Infection Rates

Proactive use of MicroCure+ Ag+ on at-risk skin can lower the incidence of ulcer infection.

Accelerate Healing Time

Effective bioburden control with DermaSept+ HOCl creates an optimal environment for wound healing.

Lower Healthcare Costs

Preventing amputations and reducing hospital stays leads to significant cost savings for the healthcare system.

Elevate Your Standard of Podiatric Care.

Integrate advanced antimicrobial technologies into your practice.

Request Clinical Evaluation Pack

Contact your medical representative for detailed protocols and pricing.

Supporting Clinical References

  • 1. Fejfar, Z., et al. (2021).

    The burden of diabetic foot ulcers in Malaysia. Journal of the ASEAN Federation of Endocrine Societies, 36(S2), 58.

  • 2. Harriott, M. M., et al. (2019).

    The effect of hypochlorous acid on killing, biofilm removal, and resistance of pathogenic bacteria. Journal of Wound Care, 28(9), 596-605.

  • 3. Khansa, I., et al. (2019).

    Silver in wound care-a review. Journal of Burn Care & Research, 40(4), 381-389.

✨ Ask our AI Clinical Assistant